Skip to content

Clinical trials

Phase 2/3 Peripheral Arterial Disease trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Peripheral Arterial Disease Phase: Phase 2/3 Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20072
20082
20102
20112
20122
20132
20141
20154
20181
20191
20241
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status6
Terminated3
Not yet recruiting1
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Flanders Medical Research Program4
Spectranetics Corporation2
Artgen Biotech1
Asklepios Kliniken Hamburg GmbH1
Brigham and Women's Hospital1
CSL Behring1
Concept Medical Inc.1
Dexa Medica Group1
Dr. Grant Pierce1
Karolinska Institutet1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Peripheral Arterial Disease22
Chronic Limb-Threatening Ischemia4
Diabetes Mellitus4
Peripheral Vascular Diseases4
Atherosclerosis3
Arterial Occlusive Diseases2
Intermittent Claudication2
Bites and Stings1
Cardiovascular Diseases1
Constriction, Pathologic1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.